Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel

J Caers, B Paiva, E Zamagni, X Leleu, J Bladé, S Y Kristinsson, C Touzeau, N Abildgaard, E Terpos, R Heusschen, E Ocio, M Delforge, O Sezer, M Beksac, H Ludwig, G Merlini, P Moreau, S Zweegman, M Engelhardt, L Rosiñol

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

205 Downloads (Pure)

Abstrakt

Solitary plasmacytoma is an infrequent form of plasma cell dyscrasia that presents as a single mass of monoclonal plasma cells, located either extramedullary or intraosseous. In some patients, a bone marrow aspiration can detect a low monoclonal plasma cell infiltration which indicates a high risk of early progression to an overt myeloma disease. Before treatment initiation, whole body positron emission tomography-computed tomography or magnetic resonance imaging should be performed to exclude the presence of additional malignant lesions. For decades, treatment has been based on high-dose radiation, but studies exploring the potential benefit of systemic therapies for high-risk patients are urgently needed. In this review, a panel of expert European hematologists updates the recommendations on the diagnosis and management of patients with solitary plasmacytoma.

OriginalsprogEngelsk
Artikelnummer10
TidsskriftJournal of Hematology & Oncology
Vol/bind11
Antal sider10
DOI
StatusUdgivet - 16. jan. 2018

Fingeraftryk Dyk ned i forskningsemnerne om 'Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel'. Sammen danner de et unikt fingeraftryk.

Citationsformater